Koers Entia Biosciences, Inc. Other OTC
Aandelen
ERGO
US29384E1047
Biotechnologie & Medisch Onderzoek
Omzet 2015 | 347K 322K | Omzet 2016 | 265K 247K | Marktkapitalisatie | 1,58 mln. 1,46 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | -2 mln. -1,86 mln. | Nettowinst (verlies) 2016 | -1 mln. -929K | EV/omzet 2015 | 8,29 x |
Nettoschuld 2015 | 255K 237K | Nettoschuld 2016 | 970K 901K | EV/omzet 2016 | 9,59 x |
K/w-verhouding 2015 |
-0,97
x | K/w-verhouding 2016 |
-1,13
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 99,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 67 | 01-10-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,86 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,66 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+28,07% | 12,14 mld. | |
+0,17% | 12,15 mld. | |
-1,24% | 11,99 mld. |